4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and subsequent hepatocellular carcinoma. HCV genotype 4 is found widely in the Middle East, Egypt and Africa, and has also spread into Europe. There are limited data available regarding the use of direct-acting antiviral agents in HCV genotype 4-infected patients with cirrhosis.

          Related collections

          Author and article information

          Journal
          Aliment. Pharmacol. Ther.
          Alimentary pharmacology & therapeutics
          Wiley-Blackwell
          1365-2036
          0269-2813
          February 2017
          : 45
          : 3
          Affiliations
          [1 ] Hospital Vall d'Hebron and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
          [2 ] University Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
          [3 ] Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
          [4 ] Quirón Valencia Hospital, Valencia, Spain.
          [5 ] Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
          [6 ] Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain.
          [7 ] Hospital Universitari Germans Trias i Pujol (CIBERehd), Barcelona, Spain.
          [8 ] Valme University Hospital University of Seville, Sevilla, Spain.
          [9 ] Hospital Ramón y Cajal, Madrid, Spain.
          [10 ] Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), University Hospital Virgen del Rocío, Sevilla, Spain.
          [11 ] Janssen Pharmaceutica NV, Beerse, Belgium.
          [12 ] Janssen Research & Development, LLC, Titusville, NJ, USA.
          Article
          10.1111/apt.13883
          27896822
          e9bd4cfb-1702-4aa5-8453-b4b5178514f8
          History

          Comments

          Comment on this article